Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 94.57M P/E - EPS this Y 74.50% Ern Qtrly Grth -
Income -59.49M Forward P/E -1.70 EPS next Y 31.10% 50D Avg Chg 1.00%
Sales 1.68M PEG - EPS past 5Y - 200D Avg Chg -17.00%
Dividend N/A Price/Book 1.02 EPS next 5Y - 52W High Chg -97.00%
Recommedations 2.50 Quick Ratio 5.82 Shares Outstanding 78.60M 52W Low Chg 42.00%
Insider Own 23.26% ROA -35.84% Shares Float 26.11M Beta 2.05
Inst Own 54.20% ROE -70.32% Shares Shorted/Prior 176.06K/47.03K Price 1.21
Gross Margin 51.19% Profit Margin - Avg. Volume 200,525 Target Price 0.65
Oper. Margin -1,551.80% Earnings Date - Volume 16,843 Change 0.00%
About Akili, Inc.

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. Akili, Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.

Akili, Inc. News
03/03/24 Akili Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
04:01 PM Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
02/27/24 PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
02/26/24 Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
02/21/24 Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates
01/15/24 Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
08:22 AM Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
12/21/23 Akili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Know
12/18/23 EndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17
11/13/23 Akili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call Transcript
11/09/23 Akili Reports Third Quarter 2023 Financial Results and Provides Business Update
10/19/23 Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET
10/12/23 Employees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study Finds
10/06/23 Akili Announces Leadership Transition
09/21/23 Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD
09/15/23 Insider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili Inc
09/13/23 Akili Announces Business Transformation, Focusing on Non-prescription Model
08/14/23 Akili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call Transcript
08/11/23 Q2 2023 Akili Inc Earnings Call
08/10/23 Akili Reports Second Quarter 2023 Financial Results and Provides Business Update
AKLI Chatroom

User Image tm0801 Posted - 11 hours ago

$AKLI covering after Monday open dip and loading up. Reversal and 30% pop I can't see it breaking more than that. The sector just doesn't have volume but I'll take 30% next week

User Image PROTRADERWALSTREET Posted - 15 hours ago

$AKLI hola….

User Image PROTRADERWALSTREET Posted - 17 hours ago

$AKLI dip runner patent and japan…

User Image tm0801 Posted - 19 hours ago

$AKLI let's goooooooooo dropping back down to 25 cents after the pump on worthless news

User Image tm0801 Posted - 1 day ago

$AKLI suck it bulls

User Image Fullratio Posted - 1 day ago

$AKLI gross profit has soared by 147% QoQ: https://fullratio.com/stocks/nasdaq-akli/akili

User Image sunsetkey1 Posted - 1 day ago

$AKLI wild.... Company gets a new patent yesterday and they don't make a press release??

User Image premarketmaker Posted - 1 day ago

$AKLI recent positive news with Japanese stock .41 is top line

User Image PROTRADERWALSTREET Posted - 1 day ago

$AKLI hola…

User Image tm0801 Posted - 1 day ago

$AKLI plummeting another 20% today. after over a million shares bought in last few minutes yesterday shorts were able to drive it even lower than previous close on only 100k shares. Shorts have unlimited ammo

User Image tm0801 Posted - 2 days ago

$AKLI 😂😂😂😂😂 it lost even more than it pumped in a half hour bwahahaha under 30 cents already

User Image premarketmaker Posted - 2 days ago

$AKLI so far - .56 could hit .60 or higher - low float/short interest

User Image premarketmaker Posted - 2 days ago

$AKLI here is why exec's are buying

User Image tm0801 Posted - 2 days ago

$AKLI 😂😂😂😂😂😂😂 loses it all in 5 minutes AH bwahahahahahaha

User Image sunsetkey1 Posted - 2 days ago

$AKLI anyone see anything??? That's crazy volume last 2 minutes....

User Image premarketmaker Posted - 2 days ago

$AKLI watch .41 mulitple PRs

User Image VrtcIl Posted - 2 days ago

If $AKLI breaks 1, the next target is 2. Keep in mind that after it breaks over a level it should not fall below once again and stay there. Price: 0.39 Float: 41.8M Short Float: 2.1 % 💰 Dollar Volume: 252.9K ℹ️ USA | Health Information Services

User Image premarketmaker Posted - 2 days ago

$AKLI ownership

User Image AlertsAndNews Posted - 2 days ago

$AKLI US patent application 17/890,478 titled "COGNITIVE PLATFORM FOR DERIVING EFFORT METRIC FOR OPTIMIZING COGNITIVE TREATMENT (USING DATA COMPUTED WITH ARTIFICIAL NEURAL NETWORK OR DEEP LEARNING TECHNIQUES)". patent news into the close

User Image sunsetkey1 Posted - 2 days ago

$AKLI wow......

User Image RollingDollar Posted - 2 days ago

$AKLI

User Image RollingDollar Posted - 2 days ago

$AKLI

User Image PatentGrants Posted - 2 days ago

$AKLI Akili has received a Notice of Allowance for US patent application 17/890,478 titled "COGNITIVE PLATFORM FOR DERIVING EFFORT METRIC FOR OPTIMIZING COGNITIVE TREATMENT (USING DATA COMPUTED WITH ARTIFICIAL NEURAL NETWORK OR DEEP LEARNING TECHNIQUES)". https://patentcenter.uspto.gov/applications/17890478/ifw/docs

User Image pfchangs Posted - 3 days ago

$AKLI have any of you ever actually done a deep dive on what this company actually does? Because I didn't come away from it wanting to invest, I came away from it wanting to create my own digital medicine company because it looks easy as fuck. anyone else with a little unity experience want to start a "digital medicine company" with me?

User Image PROTRADERWALSTREET Posted - 3 days ago

$AKLI hola…

User Image tm0801 Posted - 3 days ago

$AKLI will be red end of day as always

User Image RollingDollar Posted - 3 days ago

$AKLI

User Image Justymice Posted - 3 days ago

$AKLI here comes fomo

User Image VrtcIl Posted - 3 days ago

$AKLI still gaining momentum towards 1$. The trend is supported by consistent elevated highs and elevated lows, with notable volume signaling increased buying interest. Price: 0.31 Float: 41.8M Short Float: 0.1 % 💰 Dollar Volume: 0.5K ℹ️ USA | Health Information Services

User Image PROTRADERWALSTREET Posted - 3 days ago

$AKLI hola!news 1?

Analyst Ratings
Credit Suisse Outperform Aug 11, 23
Morgan Stanley Equal-Weight Jan 25, 23
Morgan Stanley Equal-Weight Dec 28, 22
B of A Securities Neutral Nov 18, 22
Credit Suisse Outperform Nov 15, 22
Credit Suisse Outperform Oct 25, 22
Cowen & Co. Outperform Sep 6, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Studer Jacqueline Chief Legal Officer Chief Legal Officer Sep 11 Sell 1.05 1,130 1,186 348,292 09/14/23
Martucci Walter Edward II Chief Executive Offi.. Chief Executive Officer Sep 11 Sell 1.05 2,353 2,471 3,150,180 09/14/23
Franklin Matthew President & COO President & COO Sep 11 Sell 1.05 1,728 1,814 753,898 09/14/23
Shanbhag Santosh Chief Financial Offi.. Chief Financial Officer Sep 11 Sell 1.05 830 872 323,636 09/14/23